Metabolic syndrome in antiphospholipid syndrome versus rheumatoid arthritis and diabetes mellitus: Association with arterial thrombosis, cardiovascular risk biomarkers, physical activity, and coronary atherosclerotic plaques

BACKGROUND: Cardiovascular disease (CVD) is the foremost cause of morbidity and deaths in antiphospholipid syndrome (APS), driven by thrombo-inflammation and atherothrombosis mechanisms. Metabolic syndrome (MetS) is a proinflammatory and prothrombotic state characterized by increased CVD risk. We ai...

Descripción completa

Detalles Bibliográficos
Autores principales: Bolla, Eleana, Tentolouris, Nikolaos, Sfikakis, Petros P., Tektonidou, Maria G.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Immunology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9868803/
https://www.ncbi.nlm.nih.gov/pubmed/36700208
http://dx.doi.org/10.3389/fimmu.2022.1077166

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9868803/
https://www.ncbi.nlm.nih.gov/pubmed/36700208
http://dx.doi.org/10.3389/fimmu.2022.1077166

Ejemplares similares